Mode
Text Size
Log in / Sign up
N/A N=164 Randomized Quadruple-blind Treatment

Disposable Powered Articulating Linear Cutter Stapler in Gastrointestinal Tissue Cutting and Anastomosis

Gastrointestinal Neoplasm

Enrolled (actual)
164
Serious AEs
12.5%
Results posted
Nov 2023
Primary outcome: Primary: Number of Participants With Anastomosis Success — 80; 80 Participants — p=<0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Disposable Powered Articulating Endoscopic Linear Cutter Stapler (Device); ECHELON Flex Powered Articulating Endoscopic Linear Cutters (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Fengh Medical Co., Ltd.
Primary completion
Feb 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Anastomosis Success
80; 80 <0.05 sig

Summary

To evaluate whether the anastomosis success rate of the main effectiveness evaluation indexes is not inferior to the similar products produced by Johnson & Johnson when the Fengh Disposable Powered Articulating Endoscopic Linear Cutter Stapler Used for Gastrointestinal Tissue Cutting and Anastomosis

Eligibility Criteria

Inclusion Criteria

  • The subjects are 18 ~ 75 years old, regardless of gender:
  • Subjects need to use a linear stapler for gastrointestinal tissue cutting and anastomosis:
  • The subject or his legal representative can understand the purpose of the study and show sufficient compliance with the study protocol And sign informed consent.

Exclusion Criteria

  • The subject plans to perform emergency gastrointestinal surgery:
  • Subjects with moderate malnutrition (BML 1.5;
  • Subject forced expiratory volume per second (FEV1) / expected value ≤ 50%, or forced expiratory volume per second (FEV1) / forced vital capacity (FCV) 10.0mmol/l before operation:
  • The subjects were pregnant or lactating women; Page 16 of 53 Version No.: 1.1/version date 20190125 Clinical trial on the efficacy and safety of linear cutting stapler and components for disposable electric endoscopy for cutting and anastomosis of gastrointestinal tissue
  • Subjects participated in clinical trials of other drugs or devices within 3 months before the trial;
  • Other conditions that the researchers judged not suitable for inclusion.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05320029). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search